ProKidney Corp.PROKNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+40.3%
5Y CAGR+11.2%
Year-over-Year Change

Research and development spending

3Y CAGR
+40.3%/yr
Annual compound
5Y CAGR
+11.2%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$127.67M+19.6%
2023$106.71M+30.0%
2022$82.07M+77.4%
2021$46.26M+119.8%
2020$21.04M-72.0%
2019$75.22M-